Literature DB >> 10078548

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

J Janson1, R H Ashley, D Harrison, S McIntyre, P C Butler.   

Abstract

NIDDM is characterized by islet amyloid deposits and decreased beta-cell mass. Islet amyloid is derived from the locally expressed protein islet amyloid polypeptide (IAPP). While it is now widely accepted that abnormal aggregation of IAPP has a role in beta-cell death in NIDDM, the mechanism remains unknown. We hypothesized that small IAPP aggregates, rather than mature large amyloid deposits, are cytotoxic. Consistent with this hypothesis, freshly dissolved human (h)-IAPP was cytotoxic when added to dispersed mouse and human islet cells, provoking the formation of abnormal vesicle-like membrane structures in association with vacuolization and cell death. Human islet cell death occurred by both apoptosis and necrosis, predominantly between 24 and 48 h after exposure to h-IAPP. In contrast, the addition to dispersed islet cells of matured h-IAPP containing large amyloid deposits of organized fibrils was seldom associated with vesicle-like structures or features of cell death, even though the cells were often encased in the larger amyloid deposits. Based on these observations, we hypothesized that h-IAPP cytotoxicity is mediated by membrane damage induced by early h-IAPP aggregates. Consistent with this hypothesis, application of freshly dissolved h-IAPP to voltage-clamped planar bilayer membranes (a cell-free in vitro system) also caused membrane instability manifested as a marked increase in conductance, increased membrane electrical noise, and accelerated membrane breakage, effects that were absent using matured h-IAPP or rat IAPP solutions. Light-scattering techniques showed that membrane toxicity corresponded to h-IAPP aggregates containing approximately 25-6,000 IAPP molecules, an intermediate-sized amyloid particle that we term intermediate-sized toxic amyloid particles (ISTAPs). We conclude that freshly dissolved h-IAPP is cytotoxic and that this cytotoxicity is mediated through an interaction of ISTAPs with cellular membranes. Once ISTAPs mature into amyloid deposits comprising >10(6) molecules, the capacity of h-IAPP to cause membrane instability and islet cell death is significantly reduced or abolished. These data may have implications for the mechanism of cell death in other diseases characterized by local amyloid formation (such as Alzheimer's disease).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078548     DOI: 10.2337/diabetes.48.3.491

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  211 in total

1.  How type II diabetes-related islet amyloid polypeptide damages lipid bilayers.

Authors:  Chang-Chun Lee; Yen Sun; Huey W Huang
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.

Authors:  Jacqueline F Aitken; Kerry M Loomes; Barbara Konarkowska; Garth J S Cooper
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

3.  Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide.

Authors:  Mazin Magzoub; Andrew D Miranker
Journal:  FASEB J       Date:  2011-12-19       Impact factor: 5.191

4.  Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling.

Authors:  J Bailey; K J Potter; C B Verchere; L Edelstein-Keshet; D Coombs
Journal:  Phys Biol       Date:  2011-11-25       Impact factor: 2.583

5.  Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.

Authors:  Jeffrey R Brender; Samer Salamekh; Ayyalusamy Ramamoorthy
Journal:  Acc Chem Res       Date:  2011-09-25       Impact factor: 22.384

Review 6.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

7.  Islet amyloid polypeptide toxicity and membrane interactions.

Authors:  Ping Cao; Andisheh Abedini; Hui Wang; Ling-Hsien Tu; Xiaoxue Zhang; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

8.  Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.

Authors:  Juan R Peinado; Furqan Sami; Nina Rajpurohit; Iris Lindberg
Journal:  FEBS Lett       Date:  2013-09-13       Impact factor: 4.124

9.  Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.

Authors:  Kathryn Aston-Mourney; Sakeneh Zraika; Jayalakshmi Udayasankar; Shoba L Subramanian; Pattie S Green; Steven E Kahn; Rebecca L Hull
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.